The market has been high on Puma Biotechnology Inc (PBYI) stock recently. PBYI gets a Bullish score from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With PBYI Stock Today?
Puma Biotechnology Inc (PBYI) stock has gained 9.25% while the S&P 500 is down -0.49% as of 11:32 AM on Monday, Jan 25. PBYI has risen $1.03 from the previous closing price of $11.14 on volume of 295,323 shares. Over the past year the S&P 500 is up 17.85% while PBYI has risen 51.18%. PBYI lost -$1.43 per share in the over the last 12 months.
To screen for more stocks like Puma Biotechnology Inc click here.
More About Puma Biotechnology Inc
Puma Biotechnology is a biotechnology company focused on developing novel therapeutics for the treatment of cancer. Puma licenses the commercial rights to its current drug candidates. The company expects to augment its product pipeline by acquiring, through license or otherwise, additional drug candidates for research and development and potential commercialization. In evaluating potential drug candidates, Puma employs disciplined decision criteria favoring drug candidates that have undergone at least some clinical study.
Click Here to get the full Stock Score Report on Puma Biotechnology Inc (PBYI) Stock.
